Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 69% ± 14% | |
lung | 18 studies | 68% ± 16% | |
intestine | 13 studies | 60% ± 25% | |
brain | 13 studies | 34% ± 14% | |
eye | 10 studies | 52% ± 19% | |
kidney | 9 studies | 66% ± 19% | |
lymph node | 6 studies | 73% ± 15% | |
liver | 6 studies | 63% ± 18% | |
pancreas | 5 studies | 78% ± 25% | |
bone marrow | 5 studies | 44% ± 18% | |
uterus | 5 studies | 73% ± 23% | |
placenta | 4 studies | 76% ± 23% | |
prostate | 4 studies | 76% ± 19% | |
breast | 4 studies | 81% ± 6% | |
heart | 3 studies | 34% ± 16% | |
adrenal gland | 3 studies | 69% ± 9% | |
esophagus | 3 studies | 66% ± 24% | |
skin | 3 studies | 57% ± 25% | |
thymus | 3 studies | 75% ± 28% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7865.22 | 1445 / 1445 | 100% | 780.88 | 183 / 183 |
ovary | 100% | 7995.56 | 180 / 180 | 100% | 1160.61 | 430 / 430 |
pancreas | 100% | 5905.04 | 328 / 328 | 100% | 536.35 | 178 / 178 |
stomach | 100% | 7511.61 | 359 / 359 | 100% | 854.53 | 286 / 286 |
brain | 100% | 9187.03 | 2639 / 2642 | 100% | 1208.21 | 705 / 705 |
intestine | 100% | 8367.55 | 966 / 966 | 100% | 876.13 | 526 / 527 |
uterus | 100% | 7492.92 | 170 / 170 | 100% | 762.76 | 458 / 459 |
skin | 100% | 8698.06 | 1808 / 1809 | 100% | 710.60 | 471 / 472 |
thymus | 100% | 7675.07 | 652 / 653 | 100% | 616.28 | 604 / 605 |
kidney | 100% | 10168.09 | 89 / 89 | 100% | 535.08 | 898 / 901 |
prostate | 100% | 8452.43 | 245 / 245 | 99% | 638.74 | 499 / 502 |
breast | 100% | 8843.98 | 459 / 459 | 99% | 737.11 | 1111 / 1118 |
liver | 100% | 5795.83 | 225 / 226 | 100% | 496.25 | 405 / 406 |
lung | 100% | 7463.19 | 576 / 578 | 100% | 794.31 | 1151 / 1155 |
bladder | 100% | 7507.33 | 21 / 21 | 99% | 761.04 | 498 / 504 |
adrenal gland | 100% | 21529.66 | 258 / 258 | 98% | 825.34 | 226 / 230 |
adipose | 100% | 8352.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 567.02 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1075.26 | 29 / 29 |
muscle | 100% | 14676.46 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7481.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 693.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 280.13 | 1 / 1 |
blood vessel | 100% | 9460.21 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 9061.67 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 8063.47 | 900 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0007005 | Biological process | mitochondrion organization |
GO_1905448 | Biological process | positive regulation of mitochondrial ATP synthesis coupled electron transport |
GO_0043467 | Biological process | regulation of generation of precursor metabolites and energy |
GO_1900037 | Biological process | regulation of cellular response to hypoxia |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
Gene name | CHCHD2 |
Protein name | Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein) (NS2TP) |
Synonyms | C7orf17 AAG10 |
Description | FUNCTION: Transcription factor. Binds to the oxygen responsive element of COX4I2 and activates its transcription under hypoxia conditions (4% oxygen), as well as normoxia conditions (20% oxygen) . . |
Accessions | ENST00000395422.4 Q9Y6H1 |